COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 67: Articles 661-670  | Next

Deep learning-based 3D spatial transcriptomics with X-Pression
Turos, D., Gladiseva, L., Botos, M., He, C., Barut, G. T., Veiga, I. B., Ebert, N., Bonnin, A., Chanfon, A., Grau-Roma, L., Valdeolivas, A., Rottenberg, S., Thiel, V., Moreira, E. A.
10.1101/2025.03.21.644627 — Posted: 2025-03-24
Molecular basis of sarbecovirus evolution and receptor tropism in natural hosts, potential intermediate hosts, and humans
Kosugi, Y., Matsumoto, K., Lytras, S., Plianchaisuk, A., Tolentino, J. E., Fujita, S., Yo, M. S., Luo, C., Kim, Y., Shihoya, W., Ito, J., Nureki, O., Sato, K.
10.1101/2025.03.22.644775 — Posted: 2025-03-24
Suitability of just-in-time adaptive intervention in post-COVID-19-related symptoms: A systematic scoping review
Schaap, G., Butt, B., Bode, C.
10.1101/2025.03.21.25324376 — Posted: 2025-03-23
TGF-β inhibitor SB431542 suppresses coronavirus replication through multistep inhibition
Verma, A., Kumar, G., Khandelwal, N., Mayer, B. E., Rathee, J., Chander, Y., Nokhwal, A., Dhanda, S., Kumar, R., Kamboj, H., Thachamvally, R., Sharma, S., Kumar, N.
10.1101/2025.03.20.644376 — Posted: 2025-03-21
Immune Antibodies Recognizing the Stem Region of SARS-CoV-2 Spike Protein: Molecular Modelling and In Vitro Study of Synthetic Peptides Presentation to the Antibodies
Aliper, E. T., Ryzhov, I. M., Obukhova, P. S., Tuzikov, A. B., Galanina, O. E., Ziganshina, M. M., Sukhikh, G. T., Krylov, N. A., Henry, S. M., Efremov, R. G., Bovin, N. V.
10.1101/2025.03.20.644166 — Posted: 2025-03-21
Tuberculosis services delivery challenges and their mitigations during the COVID-19 pandemic in Tanzania: A qualitative study
Pamba, D., Sanga, E., William, W., Mvungi, H., Omary, H., Setebe, T., Olomi, W., Mangu, C., Sabi, I., Balama, R., Matechi, E., Kisonga, R., Tarimo, A., Ntinginya, N. E., Maganga, L.
10.1101/2025.03.19.25324251 — Posted: 2025-03-20
Inequalities in NHS Staff Support among those from Ethnic Minority and Migrant groups during the COVID-19 Pandemic.
Croak, B., Lamb, D., Stevelink, S., Bhundia, R., Onwumere, J., Dempsey, B., Almeida-Meza, P., Chui, Z., Greenberg, N., Raine, R., Woodhead, C., Hatch, S., Rhead, R.
10.1101/2025.03.19.25324242 — Posted: 2025-03-20
Turning Challenges into Opportunities: Lessons from Ethiopias COVID-19 Response for Strengthening Health Systems and Health Security
Mossie, M. Y., Shannon, J., Desta, A. B., Brhanesilassie, E., Dufera, A., Nawaz, S.
10.1101/2025.03.17.25324158 — Posted: 2025-03-19
Capturing SARS-CoV-2 immune landscapes to inform future strategies for COVID-19 vaccination in a high-income setting: a mathematical modelling study
Hogan, A. B., Muscatello, D. J., Liu, B., Nedjati-Gilani, G., Wood, J. G.
10.1101/2025.03.18.25324222 — Posted: 2025-03-19
Wearable heart rate variability monitoring identifies autonomic dysfunction and thresholds for post-exertional malaise in Long COVID
Ruijgt, T., Slaghekke, A., Ellens, A., Janssen, K., Wust, R. C.
10.1101/2025.03.18.25320115 — Posted: 2025-03-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).